VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by mmayeron Sep 27, 2020 9:13pm

96 Views

Post# 31627348

RE:RE:RE:RE:RE:RE:RE:RE:PARTNERSHIP NEWS IMMINENT

Last MD&A states 70-100 units translates to break even

wealth2015 wrote: hospitals are open 365/24, lets try to put some numbers for pay per use, if they have only 4 uses on average per day lets speculate $100 per use that is : $100x4x365= $146,000, lets be conservative 1 use per day $100x1x365= $36,500 and that's revenue for 1 unit, lets dream and condider 70 units in next year as GA was speculating.... $2,555,000 with only one average use or $10,220,000 for 4 daily before expenses....what do you think shares will be trading at?

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments